Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
10
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Jenusaitis Matthew | Director | 6 | $10.0K | $0 | 2021-08-25 |
| Gray Robert | Director | 6 | $12.5K | $0 | 2021-06-16 |
| Glickman Marc H. | SVP & Chief Medical Officer | 6 | $9.4K | $0 | 2021-05-21 |
| BERMAN ROBERT ANDREW | Chief Executive Officer | 8 | $66.4K | $0 | 2021-05-18 |
| Duhay Francis | Director | 6 | $50.6K | $0 | 2021-05-17 |
| Glynn Craig | Chief Financial Officer | 2 | $0 | $0 | 2021-02-18 |
| Shrivastava Sanjay | Director | 7 | $0 | $0 | 2021-02-18 |
| Biodyne Holding, S.A. | Other | 32 | $0 | $1.32M | 2020-08-21 |
| Robins Marcus W. | Director | 2 | $0 | $0 | 2018-11-27 |
| Broennimann Benedict | Chief Medical Officer, OUS | 1 | $0 | $0 | 2018-11-27 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Jenusaitis Matthew | Director | P Buy | 2021-08-25 | 2021-08-27 | 1,300 | $7.70 | $10.0K | 4,842 | SEC↗ |
| Gray Robert | Director | P Buy | 2021-06-16 | 2021-06-21 | 2,000 | $6.25 | $12.5K | 5,572 | SEC↗ |
| Glickman Marc H. | SVP & Chief Medical Officer | P Buy | 2021-05-21 | 2021-05-25 | 1,600 | $5.90 | $9.4K | 1,600 | SEC↗ |
| BERMAN ROBERT ANDREW | Chief Executive Officer | P Buy | 2021-05-18 | 2021-05-19 | 3,000 | $5.47 | $16.4K | 3,736 | SEC↗ |
| Duhay Francis | Director | P Buy | 2021-05-17 | 2021-05-19 | 9,492 | $5.33 | $50.6K | 13,160 | SEC↗ |
| Glickman Marc H. | SVP & CMO | A Award deriv | 2021-02-18 | 2021-02-22 | 406,000 | — | $0 | 406,000 | SEC↗ |
| Gray Robert | Director | A Award deriv | 2021-02-18 | 2021-02-22 | 5,673 | — | $0 | 5,673 | SEC↗ |
| BERMAN ROBERT ANDREW | Chief Executive Officer | A Award deriv | 2021-02-18 | 2021-02-22 | 838,000 | — | $0 | 838,000 | SEC↗ |
| Shrivastava Sanjay | Director | A Award deriv | 2021-02-18 | 2021-02-22 | 5,673 | — | $0 | 5,673 | SEC↗ |
| Jenusaitis Matthew | Director | A Award deriv | 2021-02-18 | 2021-02-22 | 5,673 | — | $0 | 5,673 | SEC↗ |
| Duhay Francis | Director | A Award deriv | 2021-02-18 | 2021-02-22 | 5,673 | — | $0 | 5,673 | SEC↗ |
| Glynn Craig | Chief Financial Officer | A Award deriv | 2021-02-18 | 2021-02-23 | 324,000 | — | $0 | 324 | SEC↗ |
| Biodyne Holding, S.A. | Other | S Sale | 2020-08-21 | 2020-10-01 | 75,000 | $0.38 | $28.5K | 1,405,433 | SEC↗ |
| Biodyne Holding, S.A. | Other | S Sale | 2020-08-20 | 2020-10-01 | 75,000 | $0.27 | $20.3K | 1,480,433 | SEC↗ |
| Biodyne Holding, S.A. | Other | S Sale | 2020-08-19 | 2020-10-01 | 50,000 | $0.30 | $15.0K | 1,555,433 | SEC↗ |
| Biodyne Holding, S.A. | Other | S Sale | 2020-08-18 | 2020-10-01 | 50,000 | $0.34 | $17.0K | 1,605,433 | SEC↗ |
| Biodyne Holding, S.A. | Other | S Sale | 2020-08-14 | 2020-10-01 | 50,000 | $0.31 | $15.5K | 1,655,433 | SEC↗ |
| Biodyne Holding, S.A. | Other | S Sale | 2020-08-03 | 2020-10-01 | 70,000 | $0.32 | $22.4K | 1,705,433 | SEC↗ |
| Biodyne Holding, S.A. | Other | S Sale | 2020-07-31 | 2020-10-01 | 5,000 | $0.34 | $1.7K | 1,775,433 | SEC↗ |
| Biodyne Holding, S.A. | Other | S Sale | 2020-07-30 | 2020-10-01 | 25,000 | $0.32 | $8.0K | 1,780,433 | SEC↗ |
| Biodyne Holding, S.A. | Other | S Sale | 2020-07-21 | 2020-10-01 | 50,000 | $0.45 | $22.5K | 1,805,433 | SEC↗ |
| Biodyne Holding, S.A. | Other | S Sale | 2020-07-20 | 2020-10-01 | 150,000 | $0.43 | $64.5K | 1,855,433 | SEC↗ |
| Glynn Craig | Chief Financial Officer | A Award deriv | 2020-07-18 | 2021-02-23 | 4,000 | — | $0 | 4,000 | SEC↗ |
| Jenusaitis Matthew | Director | A Award deriv | 2020-07-18 | 2020-10-21 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Jenusaitis Matthew | Director | A Award | 2020-07-18 | 2020-10-21 | 62,500 | — | $0 | 62,500 | SEC↗ |
| BERMAN ROBERT ANDREW | CEO | A Award deriv | 2020-07-18 | 2020-07-21 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| BERMAN ROBERT ANDREW | CEO | J Other deriv | 2020-07-18 | 2020-07-21 | 1,080,207 | — | $0 | 0 | SEC↗ |
| BERMAN ROBERT ANDREW | CEO | A Award deriv | 2020-07-18 | 2020-07-21 | 1,080,207 | — | $0 | 1,080,207 | SEC↗ |
| Gray Robert | Director | A Award deriv | 2020-07-18 | 2020-07-21 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Duhay Francis | Director | A Award deriv | 2020-07-18 | 2020-07-21 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Shrivastava Sanjay | Director | A Award deriv | 2020-07-18 | 2020-07-21 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Glickman Marc H. | SVP & CMO | A Award deriv | 2020-07-18 | 2020-07-21 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| Gray Robert | Director | A Award | 2020-07-18 | 2020-07-21 | 62,500 | — | $0 | 78,250 | SEC↗ |
| Duhay Francis | Director | A Award | 2020-07-18 | 2020-07-21 | 62,500 | — | $0 | 107,228 | SEC↗ |
| Shrivastava Sanjay | Director | A Award | 2020-07-18 | 2020-07-21 | 62,500 | — | $0 | 97,500 | SEC↗ |
| Biodyne Holding, S.A. | Other | S Sale | 2020-07-17 | 2020-10-01 | 50,000 | $0.38 | $19.0K | 2,005,433 | SEC↗ |
| Biodyne Holding, S.A. | Other | S Sale | 2020-07-16 | 2020-10-01 | 50,000 | $0.38 | $19.0K | 2,055,433 | SEC↗ |
| Biodyne Holding, S.A. | Other | S Sale | 2020-07-06 | 2020-10-01 | 6,450 | $0.39 | $2.5K | 2,105,433 | SEC↗ |
| Biodyne Holding, S.A. | Other | S Sale | 2020-07-02 | 2020-10-01 | 57,000 | $0.40 | $22.8K | 2,111,883 | SEC↗ |
| Biodyne Holding, S.A. | Other | S Sale | 2020-07-01 | 2020-10-01 | 45,000 | $0.38 | $17.1K | 2,168,883 | SEC↗ |
| Biodyne Holding, S.A. | Other | S Sale | 2020-06-29 | 2020-10-01 | 68,094 | $0.39 | $26.6K | 2,213,883 | SEC↗ |
| Biodyne Holding, S.A. | Other | S Sale | 2020-06-26 | 2020-10-01 | 80,000 | $0.38 | $30.4K | 2,281,977 | SEC↗ |
| Biodyne Holding, S.A. | Other | S Sale | 2020-06-25 | 2020-10-01 | 100,000 | $0.40 | $40.0K | 2,361,977 | SEC↗ |
| Biodyne Holding, S.A. | Other | S Sale | 2020-06-24 | 2020-10-01 | 55,530 | $0.42 | $23.3K | 2,461,977 | SEC↗ |
| Biodyne Holding, S.A. | Other | S Sale | 2020-06-23 | 2020-10-01 | 80,000 | $0.43 | $34.4K | 2,517,507 | SEC↗ |
| Biodyne Holding, S.A. | Other | S Sale | 2020-06-22 | 2020-10-01 | 63,186 | $0.46 | $29.1K | 2,597,507 | SEC↗ |
| Biodyne Holding, S.A. | Other | S Sale | 2020-06-19 | 2020-10-01 | 80,000 | $0.46 | $36.8K | 2,660,693 | SEC↗ |
| Biodyne Holding, S.A. | Other | S Sale | 2020-06-18 | 2020-10-01 | 61,640 | $0.45 | $27.7K | 2,740,693 | SEC↗ |
| Biodyne Holding, S.A. | Other | S Sale | 2020-06-17 | 2020-10-01 | 203,100 | $0.48 | $97.5K | 2,802,333 | SEC↗ |
| Biodyne Holding, S.A. | Other | S Sale | 2020-06-16 | 2020-10-01 | 150,000 | $0.43 | $64.5K | 3,005,433 | SEC↗ |
| Biodyne Holding, S.A. | Other | S Sale | 2020-06-15 | 2020-10-01 | 100,000 | $0.42 | $42.0K | 3,155,433 | SEC↗ |
| Biodyne Holding, S.A. | Other | S Sale | 2020-06-11 | 2020-10-01 | 100,000 | $0.39 | $39.0K | 3,255,433 | SEC↗ |
| Biodyne Holding, S.A. | 10% Owner | S Sale | 2020-06-03 | 2020-06-08 | 1,683 | $0.31 | $522 | 3,355,433 | SEC↗ |
| Biodyne Holding, S.A. | 10% Owner | S Sale | 2020-06-03 | 2020-06-08 | 3,900 | $0.31 | $1.2K | 3,357,116 | SEC↗ |
| Biodyne Holding, S.A. | 10% Owner | S Sale | 2020-06-02 | 2020-06-08 | 220,000 | $0.33 | $72.6K | 3,361,016 | SEC↗ |
| Jenusaitis Matthew | Director | A Award deriv | 2019-09-13 | 2020-10-21 | 78,125 | — | $0 | 78,125 | SEC↗ |
| Jenusaitis Matthew | Director | A Award deriv | 2019-09-13 | 2020-10-21 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Gray Robert | Director | A Award deriv | 2019-09-13 | 2019-09-26 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Gray Robert | Director | A Award deriv | 2019-09-13 | 2019-09-26 | 78,125 | — | $0 | 78,125 | SEC↗ |
| Glickman Marc H. | CMO and Senior Vice Presiden | D To issuer deriv | 2019-07-26 | 2019-07-30 | 184,500 | — | $0 | 0 | SEC↗ |
| Glickman Marc H. | CMO and Senior Vice Presiden | A Award deriv | 2019-07-26 | 2019-07-30 | 184,500 | — | $0 | 184,500 | SEC↗ |
| Glickman Marc H. | CMO and Senior Vice Presiden | A Award deriv | 2019-07-26 | 2019-07-30 | 180,000 | — | $0 | 180,000 | SEC↗ |
| Biodyne Holding, S.A. | 10% Owner | S Sale | 2019-06-07 | 2020-05-14 | 684,813 | $0.67 | $458.8K | 3,581,016 | SEC↗ |
| Biodyne Holding, S.A. | 10% Owner | J Other | 2019-05-21 | 2019-05-24 | 177,740 | — | $0 | 4,265,829 | SEC↗ |
| BERMAN ROBERT ANDREW | Chief Executive Officer | P Buy | 2019-03-12 | 2019-04-17 | 18,382 | $1.36 | $25.0K | 18,382 | SEC↗ |
| BERMAN ROBERT ANDREW | Chief Executive Officer | P Buy | 2019-03-12 | 2019-03-14 | 21,740 | $1.15 | $25.0K | 21,740 | SEC↗ |
| Shrivastava Sanjay | Director | A Award deriv | 2018-11-27 | 2019-11-06 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Shrivastava Sanjay | Director | A Award deriv | 2018-11-27 | 2019-11-06 | 29,183 | — | $0 | 29,183 | SEC↗ |
| Shrivastava Sanjay | Director | A Award deriv | 2018-11-27 | 2018-11-29 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Robins Marcus W. | Director | A Award deriv | 2018-11-27 | 2018-11-29 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Duhay Francis | Director | A Award deriv | 2018-11-27 | 2018-12-04 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Broennimann Benedict | Chief Medical Officer, OUS | A Award | 2018-11-27 | 2018-11-29 | 3,334 | — | $0 | 437,778 | SEC↗ |
| Shrivastava Sanjay | Director | A Award | 2018-11-27 | 2018-11-29 | 29,183 | $2.57 | $75.0K | 29,183 | SEC↗ |
| Robins Marcus W. | Director | A Award | 2018-11-27 | 2018-11-29 | 29,183 | $2.57 | $75.0K | 29,183 | SEC↗ |
| Duhay Francis | Director | A Award | 2018-11-27 | 2018-12-04 | 29,183 | $2.57 | $75.0K | 29,183 | SEC↗ |
| BERMAN ROBERT ANDREW | Chief Executive Officer | A Award deriv | 2018-09-24 | 2018-09-26 | 1,080,207 | $2.71 | $2.93M | 1,080,207 | SEC↗ |